Hansoh Pharmaceutical Group Company Limited (HKG:3692)
Hong Kong
· Delayed Price · Currency is HKD 34.14
+0.42 (1.25%)
Mar 10, 2026, 4:08 PM HKT
HKG:3692 Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 204,139 | 102,545 | 93,358 | 87,864 | 112,525 | 222,554 | Upgrade
|
| Market Cap Growth | 96.35% | 9.84% | 6.25% | -21.92% | -49.44% | 48.44% | Upgrade
|
| Enterprise Value | 174,549 | 77,426 | 72,847 | 68,167 | 95,387 | 204,073 | Upgrade
|
| Last Close Price | 33.72 | 17.09 | 15.30 | 14.25 | 18.06 | 35.65 | Upgrade
|
| PE Ratio | 38.32 | 22.04 | 25.86 | 30.08 | 33.79 | 72.95 | Upgrade
|
| Forward PE | 33.96 | 24.05 | 28.31 | 24.97 | 27.09 | 54.85 | Upgrade
|
| PS Ratio | 14.13 | 7.86 | 8.39 | 8.28 | 9.23 | 21.56 | Upgrade
|
| PB Ratio | 5.99 | 3.36 | 3.29 | 3.43 | 4.58 | 10.48 | Upgrade
|
| P/TBV Ratio | 6.05 | 3.39 | 3.31 | 3.44 | 4.58 | 10.49 | Upgrade
|
| P/FCF Ratio | 41.47 | 26.47 | 29.25 | 31.49 | 43.30 | 194.63 | Upgrade
|
| P/OCF Ratio | 38.93 | 24.95 | 27.19 | 28.35 | 35.57 | 78.39 | Upgrade
|
| PEG Ratio | 3.91 | 3.63 | 3.12 | 1.56 | 1.11 | 1.80 | Upgrade
|
| EV/Sales Ratio | 12.08 | 5.93 | 6.54 | 6.43 | 7.82 | 19.77 | Upgrade
|
| EV/EBITDA Ratio | 32.91 | 17.01 | 21.86 | 20.57 | 25.20 | 57.49 | Upgrade
|
| EV/EBIT Ratio | 35.72 | 18.65 | 24.68 | 23.13 | 27.55 | 61.97 | Upgrade
|
| EV/FCF Ratio | 35.46 | 19.99 | 22.83 | 24.43 | 36.71 | 178.47 | Upgrade
|
| Debt / Equity Ratio | 0.00 | 0.00 | 0.17 | 0.19 | 0.19 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.02 | 0.03 | 1.41 | 1.48 | 1.24 | 0.03 | Upgrade
|
| Debt / FCF Ratio | 0.03 | 0.03 | 1.49 | 1.77 | 1.81 | 0.10 | Upgrade
|
| Net Debt / Equity Ratio | -0.87 | -0.81 | -0.80 | -0.76 | -0.75 | -0.76 | Upgrade
|
| Net Debt / EBITDA Ratio | -5.61 | -5.45 | -6.80 | -5.88 | -4.90 | -4.56 | Upgrade
|
| Net Debt / FCF Ratio | -6.01 | -6.40 | -7.10 | -6.99 | -7.14 | -14.16 | Upgrade
|
| Asset Turnover | 0.40 | 0.38 | 0.32 | 0.33 | 0.41 | 0.43 | Upgrade
|
| Inventory Turnover | 1.93 | 1.82 | 2.02 | 2.03 | 2.46 | 2.25 | Upgrade
|
| Quick Ratio | 8.31 | 9.90 | 4.11 | 9.64 | 7.50 | 6.30 | Upgrade
|
| Current Ratio | 8.56 | 10.18 | 4.21 | 9.86 | 7.67 | 6.43 | Upgrade
|
| Return on Equity (ROE) | 16.21% | 16.05% | 13.53% | 12.11% | 14.31% | 16.62% | Upgrade
|
| Return on Assets (ROA) | 8.35% | 7.54% | 5.31% | 5.70% | 7.35% | 8.59% | Upgrade
|
| Return on Invested Capital (ROIC) | 92.12% | 63.34% | 43.96% | 44.33% | 50.64% | 170.48% | Upgrade
|
| Return on Capital Employed (ROCE) | 14.20% | 13.50% | 10.20% | 9.50% | 11.70% | 15.30% | Upgrade
|
| Earnings Yield | 2.57% | 4.54% | 3.87% | 3.32% | 2.96% | 1.37% | Upgrade
|
| FCF Yield | 2.41% | 3.78% | 3.42% | 3.18% | 2.31% | 0.51% | Upgrade
|
| Dividend Yield | 1.09% | 1.97% | 1.39% | 0.70% | 0.50% | 0.22% | Upgrade
|
| Payout Ratio | 38.87% | 42.51% | 19.90% | 27.56% | 14.04% | 163.49% | Upgrade
|
| Buyback Yield / Dilution | 1.10% | 1.16% | -1.52% | 1.14% | -2.04% | -7.31% | Upgrade
|
| Total Shareholder Return | 2.19% | 3.13% | -0.13% | 1.84% | -1.54% | -7.10% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.